Looking for a specific testing answer? Read about purity, vial content and report scope, or start with Cory’s letter below.
A letter from our founder
Trust should be something you can verify.
At Panda Peptides, I want the quality conversation to be simple enough to understand and specific enough to check.
Too many sellers ask you to trust a polished certificate image, a vague “99%+” badge, or a low price. None of those tells you enough on its own. I started Panda because I believed we could source research materials carefully, publish the evidence we actually have, and keep pricing fair.
Our process is still growing, but it is built to be visible. We vet suppliers, buy in defined batches, use independent analytical testing, publish batch documentation, and explain the limits of that documentation.
The point is not to claim perfection. It is to give you a trail you can follow.
It starts with the supplier
We hear from manufacturers and intermediaries constantly. Most do not move beyond the first conversation. Before we buy, we look at communication, consistency, documentation, pricing, and whether the supplier has earned enough confidence to justify a test order.
No supplier gets a permanent pass. A source can perform well for months and still miss on a product or batch. Independent testing is there because supplier trust alone is not a quality system.
We buy and release by batch
We buy around defined batches rather than a stream of one-off vials. That gives us a clear unit to test, release, document, and trace.
Third-party testing is expensive. Batch purchasing lets us pay for meaningful verification without turning every vial into a luxury item. It also gives our fulfillment team a cleaner chain from received material to released inventory.
The testing is independent
Our current and historical reports are produced by ILS Laboratories and Janoshik Analytical, two independent third-party analytical laboratories with different strengths. We select the laboratory based on the method, panel, documentation, and batch requirements—not an exclusive relationship. Read why Panda uses both laboratories.
That matters because certificate images can be copied or edited. A direct lab-hosted record gives you another way to check the compound name, batch identifier, and reported result.
We say what the report proves
Most current Panda reports focus on HPLC purity and identity or composition confirmation, as shown on the report itself. Those results are useful, but they do not automatically prove sterility, endotoxin level, heavy-metal content, residual solvents, or every other quality marker.
We only claim those additional tests when they are documented for the relevant product or batch.
I would rather publish a narrower claim we can support than borrow certainty from a test we did not run.
One batch can include more than one vial size
When multiple vial sizes are filled from the same underlying batch material, we may test a representative sample rather than every vial size individually. The report documents the tested sample and the batch evidence behind the release; it is not a separate finished-vial test for every size.
We are working toward broader batch coverage and clearer size-specific documentation as inventory turns. Until then, the page should make the distinction easy to understand.
Custody matters after testing, too
After release, inventory is stored under controlled conditions appropriate for the material, with attention to heat, light, and handling.
Once a research product leaves controlled custody, we do not place it back into sellable inventory. That can be inconvenient, but it protects the chain of custody for the next customer.
Panda exists because I did not believe the market had to choose between credible documentation and reasonable pricing. Some companies do careful work and charge far more than I think is justified. Others compete on price and ask the buyer to accept too much on faith.
We are building a different kind of company: careful about sourcing, honest about what the evidence shows, fair on price, and willing to improve in public. We will not get every part of that perfect on day one. We will show our work.
That is the standard I want Panda held to.
Reading a laboratory report
Purity, vial content and test scope: four clear answers
A result answers a specific question about the identified sample. Keep the method, sample, value and unit together when deciding what a report establishes.
Does HPLC purity tell me the amount in the vial?
No. HPLC purity and measured content are different results. Chromatographic purity describes the relative peak areas under the reported method. It is not a measurement of the vial’s total mass or a guarantee of its labeled amount. Look for a separate content result and its unit; multiplying the labeled amount by the purity percentage does not replace that measurement.
Method reference: Bachem’s quality-control guide distinguishes chromatographic purity from product content. Our COA worksheet shows original ILS examples with separate purity and content fields. Keep each laboratory’s field names and units rather than assuming “content” always means the same thing.
Does this report cover the size I am ordering?
Check the tested sample and the documented relationship to the offered lot. Panda may use representative samples when multiple sizes share underlying batch material. A report on that sample can provide batch evidence, but it is not a separate finished-vial content measurement for an untested size or every vial shipped.
Match the compound, form, lot identifier and tested amount. If the listed size differs, ask what links the offered inventory to the report and whether a size-specific result is available. If you need a result the report does not provide, leave that requirement unresolved until it is documented.
Panda’s practice is described in One batch can include more than one vial size. Verify the sample details in the relevant original report.
Does “identity confirmed” always mean mass spectrometry?
No. Read the identity method as written. Methods differ. A result identified as HPLC retention-time matching is not a mass-spectrometry result. Record the method and its reported conclusion together; a certificate heading by itself does not identify the analytical technique.
The ILS certificates linked in our PP-Tesa report guide and buffered NAD+ report guide describe HPLC-RTM identity testing. These examples explain those reports, not every batch or laboratory method.
Does an endotoxin test establish sterility?
No. Endotoxin testing and sterility testing are separate analyses. An endotoxin result reports what that named test measured for the submitted sample under its stated method. It is not a sterility result. Likewise, purity or identity results do not establish endotoxin levels, elemental impurities or residual solvents.
Only claim a separate test when a report documents it for the relevant sample. Preserve the result’s units and reporting limits: “not detected” is not the same as proving zero. None of these results establishes suitability for human or veterinary use.
For a concrete example, the original ILS certificate COA-2026-V0BGGG lists its endotoxin method and result separately from purity and content; it is not a sterility certificate.
Research use only—not for human or veterinary use. These explanations concern analytical documentation, not efficacy or regulatory approval.
From the report to the product
Review these product specifications, prices and availability alongside their published reports. Results apply to the samples and lots identified in each report, not automatically to future batches.
PP-Tesa 10mgBuffered NAD+ 500mgIpamorelinCJC-1295 no DAC + Ipamorelin